FDA Investigator Michelle J Hines

Michelle J Hines has conducted inspections on 144 sites in 4 countries as of 21 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
144
Last Inspection Date:
21 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
100008501
Countries of Inspections:
United States of America, Guatemala, Colombia, Poland
FDA Investigators that have inspected at least one site in common with Michelle J Hines:
Ademola O Daramola, Aimee K Contreras, Alexandra B Pitkin, Allen F Hall, Amir Alavi, Andrea A Branche, Angela Shepas, Anh M Lac, Armando Chavez, MS, Bichsa T Tran, Binh T Nguyen, Brandy D Brown, Brenda Chavez, Bruce W Benware, Bryce A May, Byungja E Marciante, Carla J Lundi, Carol Henderson, Carrie A Hughes, Carrie E Jolly, Caryn M Everly, Caryn M Mcnab, Cathleen A Carr Sharpe, Charles D Brown, Charles L Larson, Christina D Mello, Christopher M Jenner, Ciara J Bajulai Austin, Comyar Shoghi, Corey K Reno, Damon C Green, MD,MS, Daniel W Cline, David G Whitman, Davis, Deborah A Greco, Denise L Burosh, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Dorathy M Eischen, Dr. Mark J Seaton, PhD, Durell L Giles, Erica R Havely, Erica R Woody, Estefania Fernandez, Farwa Z Razvi, Garrad R Poole, Gene D Arcy, Iris C Macinnes, Jacob W Reynolds, James P Stallings, James P Stumpff, Janet B Abt, Janete F Guardia, Jeff M Uriarte, Jennifer A Robinson, Jennifer M Gogley, Jessica I Newman, Jin M Kim, Joanne M Schlossin, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, Johannes S Corley, John A Daubenspeck, Joseph C Yen, Joseph M Allen, Juanita Banuelos, Judy C Nepsa, Julia Ventura, Julian C Hanson, Ka L Wong, Katherine E Jacobitz, Keith C Littrell, Kenneth S Boehnen, Kevin T Gerrity, Kim Lthomas Cruse, Kirtida Patel, Korina Serrano, Kristen E Szenderski, Lakecha N Lewis, Lam, Laura A Munsterman, LCDR Wilfred A Darang, Leighton Kn Gai, Linda Thai, Lucas B Leake, Margaret M Annes, Margo C Jones, Mariza M Jafary, Mark C Saale, Mary C Wall, Matthew R Miranda, Mendoza O Wallace, Michael D Garcia, Michelle L Johnson, Michelle M Noe Varga, Mikayla K Deardorff, Minh D Phan, Myers, Nancy E Byerly, Nancy E Smith, Natalie J Ayoub, Nathan R Moon, Ngoc T Le, Nicholas Fragedakis, Nicholas L Hunt, Omotunde O Osunsanmi, Paquita F Segarra, Patricia P Wrona, Phal K Chhun, Randall N Johnson, Rebecca L Mullikin, Richard T Jensen, Richmond K Yip, Rochelle A Rolnik, Rocio Guzman Velazquez, Ronda Rloyd Jones, Samson O Oluseye, Sandra L Shire, DMD, MPA, Sara Jdent Acosta, Sean P Desbrow, Selene T Torres, Shaquenta Y Perkins, Shawn E Larson, Sheila Alaghemand, Sherri N Rohlf, MD, Sonia R Peterson, Sparky L Bartee, Stephen R Souza, Stephen T Hansen, Stuart W Russell, Sundy V Sedwick, Tamala P Magee, Tammy Vasquez Hancock, Tawny L Colling, Thao T Kwan, Theresa Kirkham (NMI), Thomas R Beilke, Timothy P Lafave, Timothy T Kapsala, Tonia L Sawyer, Trudy R Papson, Truong Xuan Nguyen (Andy), Trushani T Desai, Uttaniti Limchumroon (Tom), Vanessa R Muller, Vashti E Bocker, Vickie L Anderson, William J Leonard, Yumi J Hiramine, Yvette Mlacour Davis, Zachary A Bogorad

Michelle J Hines's Documents

Publish Date Document Type Title
August, 2019 FDA 483 David R. Hensley, MD - Form 483, 2019-08-02
June, 2019 EIR Celerion, Inc - EIR, 2019-06-05
November, 2018 FDA 483 Amy Wagelie-Steffen, MD - Form 483, 2018-11-29
September, 2020 FDA 483 Rafaelito S. Victoria, MD - Form 483, 2020-09-25
March, 2021 FDA 483 Joseph L. Lillo, D.O. - Form 483, 2021-03-22
January, 2024 FDA 483 3D Imaging Drug Design and Development - Form 483, 2024-01-31
June, 2016 EIR Pylam Products Company, Inc. - EIR, 2016-06-14
December, 2019 FDA 483 Joseph L. Lillo, D.O. - Form 483, 2019-12-09
May, 2017 EIR Joseph McCready, MD - EIR, 2017-05-09
September, 2017 FDA 483 Grzegorz Kania - Form 483, 2017-09-29
August, 2021 FDA 483 James E. Cain, M.D. - Form 483, 2021-08-27
November, 2020 FDA 483 Neil Sheth, MD - Form 483, 2020-11-24
August, 2019 EIR David R. Hensley, MD - EIR, 2019-08-02
May, 2017 FDA 483 Joseph McCready, MD - Form 483, 2017-05-09
April, 2017 FDA 483 Joseph L. Lillo, D.O. - Form 483, 2017-04-12
March, 2018 FDA 483 Maria W. Greenwald, MD - Form 483, 2018-03-20
March, 2017 EIR Madappa Kundranda, MD, PhD - EIR, 2017-03-13
March, 2017 FDA 483 Madappa Kundranda, MD, PhD - Form 483, 2017-03-13
June, 2021 EIR Mark Gotfried, M.D - EIR, 2021-06-01
October, 2017 EIR Mitesh Borad, MD - EIR, 2017-10-24
April, 2017 FDA 483 Cheryl Roth, PhD RN - Form 483, 2017-04-26
April, 2017 FDA 483 Joseph L. Lillo, D.O. - Form 483, 2017-04-17
December, 2018 FDA 483 Northfelt, Donald MD - Form 483, 2018-12-14
June, 2018 EIR Imaging Endpoints II, LLC. - EIR, 2018-06-07
April, 2018 FDA 483 Jeffrey Packer, DO - Form 483, 2018-04-20
September, 2016 FDA 483 George R. Reiss, MD - Form 483, 2016-09-29
September, 2018 FDA 483 Eddy Dagoberto Motta Roldan, M.D. - Form 483, 2018-09-13
February, 2024 FDA 483 Abdullah Mubarak, M.D. - Form 483, 2024-02-26
January, 2024 EIR 3D Imaging Drug Design and Development - EIR, 2024-02-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more